Stock OXIS INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oxis International Euronext Paris

Equities

US6918294025

End-of-day quote Euronext Paris
Other stock markets
- EUR - Intraday chart for Oxis International
03-26 GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-01 GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall MT

Chart calendar Oxis International

be07423d0607194abd43.Ex039KHL9Gpw0qG7vddUwHNybFBske8JO_0vYkRJyP8.X3dkpdGouhk0lMP_3-Udox4zIhwi2ah6DMl8KDMvh68hVEWw6vvAATGh0g~45fb93239f5bff4a8d88b1cbab3b4f6d

Upcoming events on Oxis International

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)

Past events on Oxis International

2023-12-18 14:00 Extraordinary Shareholders Meeting
2023-11-04 22:00 Society for Immunotherapy of Cancer Meeting - Abstract No:1180
2023-11-04 14:55 Society for Immunotherapy of Cancer Meeting - Abstract No:1180
2023-11-01 09:00 Q3 2023 Earnings Release
2023-08-17 15:30 H.C. Wainwright Immune Cell Engager Conference
2023-08-07 09:00 Q2 2023 Earnings Release
2023-06-28 14:00 Annual General Meeting
2023-05-24 ASTCT EBMT Joint Basic and Translational Scientific Meeting
2023-05-16 09:00 PEGS Boston Conference
2023-05-15 17:00 Q1 2023 Earnings Release
2023-03-30 17:00 Q4 2022 Earnings Release
2023-02-28 09:00 H.C. Wainwright Cell Therapy Virtual Conference
2022-12-12 18:00 American Society of Hematology Meeting - Abstract Number: 4623
2022-11-11 09:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204
2022-11-11 09:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202
2022-10-31 17:15 Q3 2022 Earnings Release
2022-10-26 19:30 LD Micro Main Event Conference
2022-10-10 14:00 Extraordinary Shareholders Meeting
2022-09-27 Extraordinary Shareholders Meeting
2022-09-13 10:30 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-6,76
-6,10
-10.89%		-57,5
-46,2
-24.59%		-21,3
-21,2
-0.2%		-13,6
-13,9
2.65%
-17,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-28,3
-16,9
-67.12%		-58,0
-46,6
-24.61%		-20,9
-21,5
2.87%		-7,60
-8,17
7.04%
-17,4

Net income
Million USD		Released
Forecast
Spread 		-38,6


-28,3
-16,9
-67.12%		-58,0
-46,3
-25.2%		-20,9
-21,5
3%		-7,60
-8,17
7.04%
-17,4

EPS
USD		Released
Forecast
Spread 		-342


-194
-6,75
-2766.67%		-61,8
-49,4
-25.1%		-19,8
-20,1
1.49%		-5,64
-6,00
6%
-10,8

Announcement Date27/03/2016/04/2128/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-18,2
-6,84
-165.6%		-5,44
-7,45
26.95%		-3,01
-5,96
49.4%		-7,02
-3,83
-83.15%		-5,78
-5,73
-0.93%		-3,67
-5,70
35.7%		-3,62
-4,15
12.75%		-3,12
-3,95
20.96%		-3,17
-3,54
10.43%
-3,88


-4,21


-4,52


-4,81

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,0
-6,56
-174.68%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

Net income
Million USD		Released
Forecast
Spread 		-18,0
-6,73
-167.95%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

EPS
USD		Released
Forecast
Spread 		-15,6
-6,20
-151.61%		-5,10
-6,90
26.09%		-3,00
-5,40
44.44%		-6,60
-3,30
-100%		-5,40
-5,70
5.26%		-0,30
-4,80
93.75%		-1,50
-3,00
50%		-1,80
-3,00
40%		-5,52
-2,70
-104.44%
-2,70


-2,70


-2,70


-3,00

Announcement Date28/03/2216/05/2215/08/2231/10/2230/03/2315/05/2307/08/2301/11/2326/03/24----

Upcoming sector events for Oxis International

Today 06:50 ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-12 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
2024-05-12 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
2024-05-12 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-12 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MEGA LIFESCIENCES: Q1 2024 Earnings Release
2024-05-12 ALMIRALL, S.A.: Q1 2024 Earnings Release
2024-05-12 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-12 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Oxis International

Today PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
Today NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
Today NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
Today ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release (Projected)
Today KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
2024-05-08 SNDL INC.: Q1 2024 Earnings Release
2024-05-08 ALEMBIC PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-08 COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Calendar Oxis International
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW